BeOne Medicines (BEIGF) Change in Acquisitions & Divestments (2015 - 2025)

BeOne Medicines (BEIGF) has 11 years of Change in Acquisitions & Divestments data on file, last reported at $1.6 million in Q4 2025.

• Change in Acquisitions & Divestments for Q4 2025 came in at $1.6 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $3.4 million (up 29.79% YoY), and the FY2025 annual result was $3.4 million, up 29.79% from the prior year.
• Change in Acquisitions & Divestments declined to $1.6 million in Q4 2025 per BEIGF's latest filing, from $1.8 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $1.1 billion in Q1 2021 and troughed at -$10000.0 in Q4 2021.
• A 5-year average of $333.4 million and a median of $211.2 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2021 and 2022: Change in Acquisitions & Divestments slumped 100.0% in 2021, then jumped 2112300.0% in 2022.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at -$10000.0 in 2021, then jumped by 2112300.0% to $211.2 million in 2022, then slumped by 49.95% to $105.7 million in 2023, then plunged by 97.49% to $2.7 million in 2024, then slumped by 38.0% to $1.6 million in 2025.
• Business Quant data shows BEIGF's Change in Acquisitions & Divestments at $1.6 million in Q4 2025, $1.8 million in Q1 2025, and $2.7 million in Q1 2024.